TScan Therapeutics Inc (TCRX)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Total Revenue | 4.06M | 3.36M | 3.1M | 6.8M | 3.15M | 3.89M | 7.21M | 566k |
| Operating Income | -15.25M | -16.58M | -18.65M | -22.74M | -24.61M | -24.75M | -21.36M | -31.37M |
| Pre Tax Income | -15.1M | -16.25M | -18.72M | -22.56M | -24.05M | -23M | -19.61M | -30.14M |
| Net Income | -15.1M | -16.25M | -18.72M | -22.56M | -24.05M | -23M | -19.61M | -30.14M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -15.1M | -16.04M | -17.75M | -21.61M | -24.61M | -24.75M | -13.36M | -31.37M |
| EBITDA | -14.04M | -15.33M | -17.17M | -21.24M | -23.31M | -23.46M | -20.08M | -30.12M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 1.09M | 10.14M | 13.54M | 21.05M |
| Operating Income | -14.21M | -26.23M | -48.64M | -66.64M | -93.46M |
| Pre Tax Income | -13.66M | -26.23M | -48.63M | -66.22M | -89.22M |
| Net Income | -13.66M | -26.23M | -48.63M | -66.22M | -89.22M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -2.591 | -4.976 | -2.034 | -1.367 | -0.933 |
| EBIT | -14.21M | -26.23M | -48.63M | -65.05M | -85.46M |
| EBITDA | -13.69M | -25M | -45.31M | -61.5M | -88.1M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
